Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Norman Roth currently holds 98,975 shares of MEDICAL TRANSCRIPTION BILLING, CORP (MTBC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Norman Roth has been a net neutral trader of MTBC stock. They have purchased $0 and sold $0 worth of shares.
Norman Roth's most recent insider trade was on May 15, 2026, when they sold 6,500 shares at $25.25 per share.
Norman Roth serves as Executive at MEDICAL TRANSCRIPTION BILLING, CORP (MTBC). They have executed 54 insider transactions totaling $0 over their tenure at the company.
Norman Roth holds the position of Executive at MEDICAL TRANSCRIPTION BILLING, CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Norman Roth has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Norman Roth was on May 15, 2026, when they sold $164.1K worth of CCLD shares. This transaction involved 6,500 shares at $25.25 per share.
Norman Roth currently owns 98,975 shares of MEDICAL TRANSCRIPTION BILLING, CORP (MTBC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Norman Roth's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Norman Roth has 54 Form 4 filings on record as an insider at MEDICAL TRANSCRIPTION BILLING, CORP.
Set alerts for Norman Roth and 40,000+ other insiders.